BALBOA DX LABORATORY
NPI 1326658097
Clinical Medical Laboratory in Murrieta, CA
NPI Status: Active since August 06, 2020
Contact Information
26359 JEFFERSON AVE STE G
MURRIETA, CA
ZIP 92562
Phone: (760) 230-9080
- Organization
- Clinical Medical Laboratory
About BALBOA DX LABORATORY
This page provides the complete NPI Profile along with additional information for Balboa Dx Laboratory, a provider established in Murrieta, California operating as a Clinical Medical Laboratory. The healthcare provider is registered in the NPI registry with number 1326658097 assigned on August 2020. The practitioner's primary taxonomy code is 291U00000X. The provider is registered as an organization and their NPI record was last updated 4 years ago. The provider's other name is Balboa Dx Laboratory. The authorized official of this NPI record is Mr. Brandon D Rainone (Owner)
- NPI
- 1326658097
- Provider Legal Name
- RDR HOLDINGS LLC
- Other Organization Name
- BALBOA DX LABORATORY
- Other Name Type
- Other Name (5)
- Entity Type
- Organization
- Location Address
- 26359 JEFFERSON AVE STE G MURRIETA, CA 92562
- Location Phone
- (760) 230-9080
- Mailing Address
- 26359 JEFFERSON AVE STE G MURRIETA, CA 92562
- Mailing Phone
- (760) 230-9080
- Is Sole Proprietor?
- No
- Is Organization Subpart?
- No
- Enumeration Date
- 08-06-2020
- Last Update Date
- 10-14-2021
- Code Navigator
Establishments like Balboa Dx Laboratory are healthcare facilities that may perform a wide range of laboratory procedures, assisted by doctors and medical technologists. Laboratories can be categorized according to their function as common diagnostic labs or specialty labs that conduct specialized or confirmatory tests. Different clinical laboratories could specialize in clinical chemistry, clinical microbiology, hematology, serology, clinical microscopy, cytopathology, molecular biology, or public health. Please inquire directly with this provider to confirm their test menu.
Location Map
Specialty - Primary Taxonomy
The NPI enumerator requires providers to submit at least one taxonomy code. A taxonomy code is a unique 10-character code that describes the healthcare provider type, classification, and the area of specialization. There could be only one primary taxonomy code per NPI record. For individual NPIs the license data is associated to the taxonomy code.
- Classification
Clinical Medical Laboratory
- Taxonomy Code
- 291U00000X
- Type
- Laboratories
- Taxonomy Description
- (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology.
Areas of Expertise
The following services and procedures, recently provided to Medicare patients, illustrate the range of care this provider offers. This list reflects the variety of services available to all patients visiting the practice and is based on 2022 Medicare dataset. In general, the more frequently a provider treats specific conditions or performs particular procedures, the more experienced they become in addressing similar patient needs. The provider has delivered many of the services listed below to Medicare patients. Please note that this list does not include services provided to patients who are not covered by Medicare.
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source
This service involves the testing for COVID-19 using advanced technologies that can process multiple samples at once. It identifies different types or subtypes of the virus, including SARS-CoV-2/2019-nCoV. This test is non-CDC but adheres to the guidelines outlined in CMS-2020-01-R.
This service was performed 94 times for 54 patientsThis is a test to detect the COVID-19 virus. It uses a technique that amplifies the virus's genetic material (DNA or RNA) for detection. High throughput technologies are used for rapid and large-scale testing. The procedure is completed within a set time frame.
This service was performed 285 times for 106 patientsThis is a test for COVID-19. It uses high-tech methods to find the virus's genetic material in your body. The amplified probe technique helps detect the virus even in small amounts. This is crucial for early detection and effective treatment.
This service was performed 499 times for 231 patientsSpecimen collection for SARS-CoV-2, the virus causing COVID-19, involves taking a sample from the nose or throat using a swab. This sample is then analyzed in a lab to detect the presence of the virus. It's a crucial step in diagnosing COVID-19.
This service was performed 387 times for 186 patientsReviews for BALBOA DX LABORATORY
There are currently no reviews for this provider. Be the first person to share your experience with this provider by filling out our review form. Your insights are appreciated and will help others make informed decisions.
NPI Validation Check Digit Calculation
The following table explains the step by step NPI number validation process using the ISO standard Luhn algorithm.
| Start with the original NPI number, the last digit is the check digit and is not used in the calculation. | |||||||||
| 1 | 3 | 2 | 6 | 6 | 5 | 8 | 0 | 9 | 7 |
| Step 1: Double the value of the alternate digits, beginning with the rightmost digit. | |||||||||
| 2 | 3 | 4 | 6 | 12 | 5 | 16 | 0 | 18 | |
| Step 2: Add all the doubled and unaffected individual digits from step 1 plus the constant number 24. | |||||||||
| 2 + 3 + 4 + 6 + 1 + 2 + 5 + 1 + 6 + 0 + 1 + 8 + 24 = 63 | |||||||||
| Step 3: Subtract the total obtained in step 2 from the next higher number ending in zero, the result is the check digit. | |||||||||
| 70 - 63 = 7 | 7 | ||||||||
The NPI number 1326658097 is valid because the calculated check digit 7 using the Luhn validation algorithm matches the last digit of the original NPI number.
Frequently Asked Questions
The NPI number assigned to this healthcare provider is 1326658097, enumerated in the NPI registry as an "organization" on August 06, 2020
The provider is located at 26359 Jefferson Ave Ste G Murrieta, Ca 92562 and the phone number is (760) 230-9080
This medical organization specializes in Clinical Medical Laboratory with taxonomy code 291U00000X
The most common procedures or services performed by this practitioner are: 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r and Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source.
This NPI record was last updated on August 06, 2020. To officially update your NPI information contact the National Plan and Provider Enumeration System (NPPES) at 1-800-465-3203 (NPI Toll-Free) or by email at [email protected].
NPI Profile data is regularly updated with the latest NPI registry information, if you would like to update or remove your NPI Profile in this website please contact us.